Abstract
Antisense and Nucleic Acid Drug DevelopmentVol. 6, No. 3 On the Quality Control of Antisense OligonucleotidesFritz Eckstein, Arthur M. Krieg, C.A. Stein, Sudhir Agrawal, Serge Beaucage, P. Dan Cook, Staney Crooke, Michael J. Gait, Alan Gewirtz, Paul Hélène, Ramaswany Miller, Angelo Nicolin, Peter Nielsen, Eiko Ohtsuka, Hartmut Seliger, Wojciech Stec, David Tidd, Richard Wagner, and Jerry ZonFritz EcksteinSearch for more papers by this author, Arthur M. KriegSearch for more papers by this author, C.A. SteinSearch for more papers by this author, Sudhir AgrawalSearch for more papers by this author, Serge BeaucageSearch for more papers by this author, P. Dan CookSearch for more papers by this author, Staney CrookeSearch for more papers by this author, Michael J. GaitSearch for more papers by this author, Alan GewirtzSearch for more papers by this author, Paul HélèneSearch for more papers by this author, Ramaswany MillerSearch for more papers by this author, Angelo NicolinSearch for more papers by this author, Peter NielsenSearch for more papers by this author, Eiko OhtsukaSearch for more papers by this author, Hartmut SeligerSearch for more papers by this author, Wojciech StecSearch for more papers by this author, David TiddSearch for more papers by this author, Richard WagnerSearch for more papers by this author, and Jerry ZonSearch for more papers by this authorPublished Online:30 Jan 2009https://doi.org/10.1089/oli.1.1996.6.149AboutSectionsPDF/EPUB Permissions & CitationsPermissionsDownload CitationsTrack CitationsAdd to favorites Back To Publication ShareShare onFacebookTwitterLinked InRedditEmail "On the Quality Control of Antisense Oligonucleotides." , 6(3), p. 149FiguresReferencesRelatedDetailsCited byGuidelines for Experiments Using Antisense Oligonucleotides and Double-Stranded RNAs Keith T. Gagnon and David R. Corey30 May 2019 | Nucleic Acid Therapeutics, Vol. 29, No. 3Methods for L-ribooligonucleotide sequence determination using LCMS24 September 2011 | Nucleic Acids Research, Vol. 39, No. 21Sequence Dependence of C5-Propynyl-dU,dC-Phosphorothioate Oligonucleotide Inhibition of the Human IGF-I Receptor: mRNA, Protein, and Cell Growth Rhys D. Fogarty, Sandra C. McKean, Paul J. White, Lynne M. Atley, George A. Werther, and Christopher J. Wraight8 July 2004 | Antisense and Nucleic Acid Drug Development, Vol. 12, No. 6Over expression of endoglin in human prostate cancer suppresses cell detachment, migration and invasion25 November 2002 | Oncogene, Vol. 21, No. 54Identification and Quantification of Protecting Groups Remaining in Commercial Oligonucleotide Products Using Monoclonal AntibodiesAnalytical Biochemistry, Vol. 306, No. 1GeneBlocs Are Powerful Tools to Study and Delineate Signal Transduction Processes That Regulate Cell Growth and Transformation Maria Sternberger, Anett Schmiedeknecht, Anny Kretschmer, Frank Gebhardt, Frauke Leenders, Frank Czauderna, Ira von Carlowitz, Mike Engle, Klaus Giese, Leonid Beigelman, and Anke Klippel8 July 2004 | Antisense and Nucleic Acid Drug Development, Vol. 12, No. 3Human cell lines expressing hormone regulated T7 RNA polymerase localized at distinct intranuclear sitesGene, Vol. 275, No. 1Antisense oligonucleotides in cutaneous therapyPharmacology & Therapeutics, Vol. 90, No. 1Antisense therapeutics: is it as simple as complementary base recognition?Molecular Medicine Today, Vol. 6, No. 2Antisense properties of peptide nucleic acidNucleic Acid Therapeutics: State of the Art and Future ProspectsBlood, Vol. 92, No. 3Antisense Inhibition of Phosphodiesterase ExpressionMethods, Vol. 14, No. 1 Volume 6Issue 3Jan 1996 To cite this article:Fritz Eckstein, Arthur M. Krieg, C.A. Stein, Sudhir Agrawal, Serge Beaucage, P. Dan Cook, Staney Crooke, Michael J. Gait, Alan Gewirtz, Paul Hélène, Ramaswany Miller, Angelo Nicolin, Peter Nielsen, Eiko Ohtsuka, Hartmut Seliger, Wojciech Stec, David Tidd, Richard Wagner, and Jerry Zon.On the Quality Control of Antisense Oligonucleotides.Antisense and Nucleic Acid Drug Development.Jan 1996.149-149.http://doi.org/10.1089/oli.1.1996.6.149Published in Volume: 6 Issue 3: January 30, 2009PDF download
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
